THELINIA

US serial number:85181202
Application filling date:Nov. 19, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned after publication because applicant filed an express abandonment. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Apr. 17, 2012
Publication date:Apr. 17, 2012
Abandoned date:Mar. 28, 2012
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmolo
Current owner owner name:Pfizer Inc.
Current owner owner address:235 East 42nd Street New York, NEW YORK UNITED STATES 10017
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Tiffany Trunko
Attorney email:deadlinesipnyo@pfizer.com
Attorney email authorized:Yes
Correspondent name address:TIFFANY TRUNKO PFIZER INC. 150 E 42ND ST NEW YORK, NEW YORK UNITED STATES 10017-5612
Correspondent phone:212-733-6491
Correspondent email:deadlinesipnyo@pfizer.com
Correspondent fax:212-573-2273
Correspondent email authorized:Yes
Trademark staff tm attorney:PARKER, JUSTINE D
Trademark staff law office assigned THELINIA:LAW OFFICE 101

Reviews

Required fields are marked *